Bioinnovo Participates in the NANOBIOTEC Seminar Series

Por admin en News

Within the framework of the NANOBIOTEC seminar series, Biochemist Hernán Ramírez, a member of the Bioinnovo team, presented his research titled “Design and evaluation of vaccine strategies for cattle against enterohemorrhagic Escherichia coli O157:H7, the causative agent of Hemolytic Uremic Syndrome in humans.”

 

The seminar took place on Monday, October 13, and is part of the academic activities Hernán is conducting at the company as part of his doctoral thesis, contributing to the advancement and consolidation of his postgraduate training.

 

The research is directed by Dr. Andrés Wigdorovitz, co-directed by Dr. Mariano Larzabal, with Dr. María Victoria Miranda serving as academic advisor. The project is being carried out at NODO INCUINTA (CYCVYA, INTA Castelar) and Bioinnovo S.A.

 

During his presentation, Hernán shared progress on the design of a bovine vaccine aimed at reducing the shedding of enterohemorrhagic Escherichia coli (EHEC) O157:H7. This zoonotic pathogen is responsible for Hemolytic Uremic Syndrome (HUS), a severe illness that primarily affects children under five years of age.

 

This development represents an innovative approach to HUS prevention by targeting the animal reservoir, thereby helping to reduce environmental and food contamination. Consequently, the project aligns with the public health and food safety objectives encompassed by the “One Health” concept, which is actively promoted by Bioinnovo and its partner institutions.

 

Vaccines are one of the most effective and safe tools for preventing infectious diseases. This work reflects the commitment of INTA, CONICET, and Bioinnovo to generating biotechnological solutions that directly impact both human and animal health.